Supplementary Table S4 from Was It Worth It? Response Data from >650 US and International Participants in Chemoprevention Trials

Read full text
Authors: David Zahrieh, Carrie A. Strand, Paul J. Limburg, Aminah Jatoi, Sumithra J. Mandrekar
Cited by: 0

Abstract

Supplementary Table S4 shows the top five most frequent adverse events overall and by trial that were reported during the preintervention and on-study periods.

Fields of Study & Subjects

Animal testing and alternatives Statistical Methods in Clinical Trials Advanced Causal Inference Techniques

Publication details

Publication date
6 January 2026